ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Lithium acetate dihydrate → (11S,11aS)-allyl 11-(tert-butyldimethylsilyloxy)-8-hydroxy-7-methoxy-5-oxo-2-((E)-prop-1-enyl)-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate

HRID 513360
印刷

反応式

HRID 513360 の反応式
O.O.C([O-])(=O)C.[Li+].[Si:8]([O:15][C@@H:16]1[N:22]([C:23]([O:25][CH2:26][CH:27]=[CH2:28])=[O:24])[C:21]2[CH:29]=[C:30]([O:35][Si](C(C)C)(C(C)C)C(C)C)[C:31]([O:33][CH3:34])=[CH:32][C:20]=2[C:19](=[O:46])[N:18]2[CH:47]=[C:48](/[CH:50]=[CH:51]/[CH3:52])[CH2:49][C@@H:17]12)([C:11]([CH3:14])([CH3:13])[CH3:12])([CH3:10])[CH3:9]>CN(C=O)C.C(OCC)(=O)C>[Si:8]([O:15][C@@H:16]1[N:22]([C:23]([O:25][CH2:26][CH:27]=[CH2:28])=[O:24])[C:21]2[CH:29]=[C:30]([OH:35])[C:31]([O:33][CH3:34])=[CH:32][C:20]=2[C:19](=[O:46])[N:18]2[CH:47]=[C:48](/[CH:50]=[CH:51]/[CH3:52])[CH2:49][C@@H:17]12)([C:11]([CH3:14])([CH3:13])[CH3:12])([CH3:9])[CH3:10]
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 2

HCID 23666338Lithium acetate dihydrateHCID 86717767(11S,11aS)-allyl 11-(tert-butyldimethylsilyloxy)-7-methoxy-5-oxo-2-((E)-prop-1-en yl)-8-(triisopropylsilyloxy)-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10 (5H)-carboxylate

生成物 1

HCID 86717766(11S,11aS)-allyl 11-(tert-butyldimethylsilyloxy)-8-hydroxy-7-methoxy-5-oxo-2-((E)-prop-1-enyl)-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate収率 45%

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒
HCID 8857Ethyl Acetate溶媒

実験手順

Lithium acetate dihydrate (0.31 g, 3.04 mmol, 1.0 eq) was added to a solution of the diazepine 11 (2.0 g, 3.04 mmol, 1.0 eq) in wet DMF (20 mL) at 25° C. and stirred for 4 hours. The reaction mixture was diluted with ethyl acetate (200 mL) and washed successively with 0.1M citric acid (50 mL, pH 3), water (50 mL) and brine (10 mL), dried over MgSO4, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography (silica gel, 50/50 v/v n-hexane/EtOAc to 25/75 v/v n-hexane/EtOAc) to afford the product as a pale yellow solid (0.68 g, 45%). LC/MS (3.352 min (ES+)), m/z: 501.1 [M+H]+. 1H NMR (400 MHz, CDCl3) δ 7.02 (s, 1H), 6.66 (m, 1H), 6.53 (s, 1H), 6.03 (d, 1H, J=15.5 Hz), 5.80 (s, 1H), 5.63 (d, 1H, J=8.9 Hz), 5.55 (m, 1H), 5.29 (m, 1H), 4.87 (m, 2H), 4.39 (dd, 1H, J=13.5, 4.2 Hz), 4.20 (dd, 1H, J=13.2, 5.7 Hz), 3.73 (s, 3H), 3.59 (m, 1H), 2.81 (dd, 1H, J=16.1, 10.5 Hz), 2.35 (d, 1H, J=15.7 Hz), 1.61 (d, 3H, J=6.4 Hz), 0.67 (s, 9H), 0.05 (s, 3H), 0.00 (s, 3H).

後処理

  1. washwashed successively with 0.1M citric acid (50 mL, pH 3), water (50 mL) and brine (10 mL)
  2. dry with materialdried over MgSO4
  3. filtrationfiltered
  4. concentrationconcentrated under reduced pressure
  5. customThe residue was purified by flash chromatography (silica gel, 50/50 v/v n-hexane/EtOAc to 25/75 v/v n-hexane/EtOAc)

出典と根拠

ORDレコード
ord-367fa8758ef04307a96af80502673fbd
出典データセット
uspto-grants-2015_08
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09102704B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート